The beneficial effect of MSCs on renal tissue was related to the inhibition of renal tubular oxidative damage in a cisplatin-induced AKI model, manifested by the expression of nitrotyrosine and induction of Akt phosphorylation (59). This evidence concerns the gene AKT1 and acute kidney injury.